Semaglutide and cardiovascular outcomes in obesity without diabetes

…, HM Colhoun, J Deanfield, SS Emerson… - … England Journal of …, 2023 - Mass Medical Soc
Background Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to
reduce the risk of adverse cardiovascular events in patients with diabetes. Whether …

The importance of the normality assumption in large public health data sets

T Lumley, P Diehr, S Emerson… - Annual review of public …, 2002 - annualreviews.org
▪ Abstract It is widely but incorrectly believed that the t-test and linear regression are valid
only for Normally distributed outcomes. The t-test and linear regression compare the mean of …

Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials.

…, SM Gapstur, RM Bostick, SS Emerson… - … , biomarkers & prevention …, 1997 - AACR
Surrogate end-point biomarkers (SEBs) have become widely used in short-term cancer
chemoprevention trials in place of cancer end points. This paper discusses criteria relevant to the …

[HTML][HTML] The prevention and treatment of missing data in clinical trials

…, ML Cohen, K Dickersin, SS Emerson… - … England Journal of …, 2012 - Mass Medical Soc
The Prevention and Treatment of Missing Data in Clinical Trials | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

[HTML][HTML] Efficacy and safety of degludec versus glargine in type 2 diabetes

…, B Zinman, NR Poulter, SS Emerson… - … England Journal of …, 2017 - Mass Medical Soc
Background Degludec is an ultralong-acting, once-daily basal insulin that is approved for
use in adults, adolescents, and children with diabetes. Previous open-label studies have …

Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study

EF McKone, SS Emerson, KL Edwards, ML Aitken - The Lancet, 2003 - thelancet.com
Background Over 1000 mutations of the cystic fibrosis transmembrane conductance regulator
gene (CFTR) that cause cystic fibrosis have been identified. We examined the effect of …

Risk of hip fracture among dialysis and renal transplant recipients

AM Ball, DL Gillen, D Sherrard, NS Weiss, SS Emerson… - Jama, 2002 - jamanetwork.com
ContextRenal failure places people at particularly high risk of hip fracture. However, the possible
differential impact of dialysis and renal transplantation on this risk is not well understood…

Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trial

JG Jarvik, W Hollingworth, B Martin, SS Emerson… - Jama, 2003 - jamanetwork.com
Context Faster magnetic resonance imaging (MRI) scanning has made MRI a potential cost-effective
replacement for radiographs for patients with low back pain. However, whether …

Evaluation of aducanumab for Alzheimer disease: scientific evidence and regulatory review involving efficacy, safety, and futility

GC Alexander, S Emerson, AS Kesselheim - Jama, 2021 - jamanetwork.com
On November 6, 2020, a US Food and Drug Administration (FDA) advisory committee
reviewed issues related to the efficacy and safety of aducanumab, a human IgG1 anti-Aβ …

The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis

S Saint, JG Elmore, SD Sullivan, SS Emerson… - The American journal of …, 1998 - Elsevier
Purpose: Indwelling urinary catheters are implicated in most cases of nosocomial urinary tract
infection. Silver-coating of catheters may reduce the risk of these infections; however, trials …